Barclays’s Inhibikase Therapeutics IKT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $215K | Buy |
110,252
+26,252
| +31% | +$51.2K | ﹤0.01% | 3482 |
|
|
2025
Q1 | $184K | Hold |
84,000
| – | – | ﹤0.01% | 3377 |
|
|
2024
Q4 | $273K | Buy |
+84,000
| New | +$273K | ﹤0.01% | 3365 |
|
|
2023
Q3 | – | Sell |
-11,455
| Closed | -$41K | – | 4311 |
|
|
2023
Q2 | $41K | Buy |
+11,455
| New | +$41K | ﹤0.01% | 3758 |
|